PATENT CLAIM ANALYSIS

Application Number: 16229509
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "450000"]

Abstract:
This disclosure provides improved lipid-based compositions, including lipid nanoparticle compositions, and methods of use thereof for delivering agents in vivo including nucleic acids and proteins. These compositions are not subject to accelerated blood clearance and they have an improved toxicity profile in vivo.

Claim (Index 22):
The LNP of  claim 20 , wherein the mRNA encodes a protein.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.27027
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15674107', '15674872', '16192274', '15846084', '16148822']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8357704553871406
- 35 USC 102 Novelty (BERT): 0.7275182762586723
- Combined Prediction Score: 0.8249452374742937
- Mean Citation Score: 648.435428
- Max Citation Score: 911.3256
- Similarity Product: 632.2167300639153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test